Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |